Cancer Medicine Journal

Journal Home Editorial Board Articles in Press Current Issue Archive Author Guidelines Submit Manuscript

Home

Cancer Medicine Journal (TRIDHA Cancer & Cancer Medicine Society) (DOI prefix: 10.46619) is an International open access, peer-reviewed journal with a broad scope covering all areas of cancer research, especially novel concepts and theories, new methods/techniques, new therapeutic agents, and alternative approaches for early detection and intervention of cancer.

Cancer Medicine Journal focuses to entrench the field of cancer or oncology by publishing articles focused upon disease management, hinderance/prevent, methods for early diagnosis, and specific classes of therapeutic agents, results of a clinical trial, an emerging interventional technique, supportive care, and rehabilitation/reconstruction. Journal provides platform for rapid publication of high quality results in cancer research while maintaining rigorous single blinded peer-review process.

Publication Fee: USD 985

At this stage, the submission and publication of manuscripts is at huge discount (USD 159) for all students/emeritus professor. The published articles are made freely available to online readers.

Authors Funded by the NIH: This journal automatically deposits papers to PubMed Central after publication of an issue (NIHMS, http://nihms.nih.gov/).

COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC    https://www.coronavirus.gov
Get the latest research    https://www.who.int/emergencies/diseases/novel-coronavirus-2019

Acceptance Rate
64%
Days to process
45
Days to publish
10
Total Articles
36

Recently Published Articles

Review Article | Volume 4, Issue 2 | Open Access
Application of Gene Therapy towards Treatment of Cancer: Potentials and Future Developments

Aliyi Hassen Jarso

Review Article | Volume 4, Issue 2 | Open Access
The Significance of Psychological Assessments for Well-Being and Quality of Life in Terminal Ill Diagnosis

Suantak Demkhosei Vaiphei

Case Series | Volume 4, Issue 2 | Open Access
Myelodysplastic Syndrome in Patients with Gastro-Pancreatic Malignancies: A Case Series and Review of Literature

Amandeep Godara, Anupama Kumar, Kenneth B Miller and Muhammad Wasif Saif

Short Communication | Volume 4, Issue 2 | Open Access
Triple mutation Negative Thrombocytosis: A Diagnostic Conundrum and DNMT3A Mutation may be an Early Event Indicating Essential Thrombocythemia

Md Serajul Islam

Editorial | Volume 4, Issue 2 | Open Access
Potential Impact of Delay in Cancer Screening due to COVID-19

Matthew I Ehrlich and Muhammad Wasif Saif

Review Article | Volume 4, Issue 1 | Open Access
Consequences of the COVID-19 Pandemic on Cancer Clinical Trials

Sally Flores, Nita Kurian, Anu Yohannan, Christina Persaud and Muhammad Wasif Saif

Review Article | Volume 4, Issue 1 | Open Access
A Wider Scope for the Antibiotic and Anticancer Drug Bleomycin

Mustapha Aouida and Dindial Ramotar

Review Article | Volume 4, Issue 1 | Open Access
Review of Oncology and Transplant Literature for the Management of Hepatic and Pancreatic Resections in Jehovah’s Witnesses

Hassan Aziz, Yuri Genyk, Muhammad Wasif Saif, Alexandra Filkins, Rick Selby and Rashid Sheikh M

Research Article | Volume 4, Issue 1 | Open Access
Is there an Ethnic Predisposition to Developing Brain Metastases (BM) in Asian Patients with Colorectal Cancer?

Kerri McGovern, Melissa H Smith, Antonia Maloney, Jyothi Jose and Muhammad Wasif Saif

Research Article | Volume 4, Issue 1 | Open Access
Safety and Efficacy of Same-Day Administration of Pegfilgrastim in Patients Receiving Chemotherapy for Gastrointestinal Malignancies

Robert M Matera, Valerie Relias and Muhammad Wasif Saif

View More

Aims & Scope

Main aim of the journal is to improve and share knowledge & global health outcomes by publishing Research article, Review, Case reports to convey important practice messages and best research should be published and made widely accessible as quickly as possible in scientific community. Cancer Medicine Journal welcome all kind of articles covering areas of Cancer Biology, Clinical Cancer Research, Cancer Prevention, and other related fields.

The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas:

  • Cancer
  • Cancer Diseases
  • Endocrine disorders
  • Breast cancer
  • Blood diseases
  • Cancer statistics
  • Cancer diagnosis
  • Carcinogenesis - etiology, mechanisms
  • Molecular biology
  • Recent developments in tumor therapy
  • General diagnosis
  • Laboratory diagnosis
  • Diagnostic and experimental pathology
  • Oncologic surgery
  • Epidemiology
  • Treatment strategies
  • Evaluations of current therapies
  • Models for integrating complementary and conventional treatment in clinical practice
  • Interventions from alternative and traditional medicine
  • Implementing quality-of-life assessment and counseling in the clinical setting
  • Cancer rehabilitation during and following cancer treatments
  • Potential interactions of cancer chemotherapy drugs with frequently used dietary supplements
  • Implementing integrative cancer care strategies into oncology practice
  • Relevant molecular mechanisms and biology behind integrative approaches
  • Impact of timing of chemotherapy administration on toxicity
  • Response, and outcome by leading oncologists
  • Researchers, and health-care professionals